Skip to content

Depression: all studies

Page 286 of 1,038: studies 2,851 to 2,860 of 10,380, newest first. Back to the depression overview

Research

Mindfulness-based Intervention in Elementary School Students With Anxiety and Depression: A Series of n-of-1 Trials on Effects and Feasibility.

Journal of Evidence-Based Complementary & Alternative Medicine August 30, 2017 Catherine Malboeuf-Hurtubise, Éric Lacourse, Catherine Herba et al.

Mindfulness-based interventions constitute a promising option to address anxiety and depression in elementary school students. This study evaluated the effect of a mindfulness-based intervention on anxiety and depression in elementary school students with a diagnosis of anxiety or depression disorder. A single-subject experimental A-B-A design was used. Participants were three elementary school...

Backing into the future: pharmacological approaches to the management of resistant depression

Psychological Medicine August 25, 2017 Philip J. Cowen 38 citations

Pragmatic studies indicate that a substantial number of depressed patients do not remit with current first-line antidepressant treatments and after two failed treatment steps the chance of remission with subsequent therapies is around 15%. This paper focuses on current evidence for pharmacological treatments in resistant depression as well as possible future developments. For patients who have...

Synaptic Regulation of a Thalamocortical Circuit Controls Depression-Related Behavior.

Cell Reports August 22, 2017 Oliver H Miller, Andreas Bruns, Imen Ben Ammar et al.

The NMDA receptor (NMDAR) antagonist ketamine elicits a long-lasting antidepressant response in patients with treatment-resistant depression. Understanding how antagonism of NMDARs alters synapse and circuit function is pivotal to developing circuit-based therapies for depression. Using virally induced gene deletion, ex vivo optogenetic-assisted circuit analysis, and in vivo chemogenetics and...

Dextromethorphan/quinidine pharmacotherapy in patients with treatment resistant depression: A proof of concept clinical trial.

Journal of Affective Disorders August 15, 2017 James W. Murrough, Elizabeth Wade, Sehrish Sayed et al.

At least one-third of patients with major depressive disorder (MDD) have treatment-resistant depression (TRD), defined as lack of response to two or more adequate antidepressant trials. For these patients, novel antidepressant treatments are urgently needed. The current study is a phase IIa open label clinical trial examining the efficacy and tolerability of a combination of dextromethorphan...

A Physician’s Attempt to Self-Medicate Bipolar Depression with N,N-Dimethyltryptamine (DMT)

Journal of Psychoactive Drugs August 8, 2017 Tanida Brown, Wanda Shao, Shehzad Ayub et al. 21 citations

N,N-dimethyltryptamine (DMT) is a psychoactive substance that has been gaining popularity in therapeutic and recreational use. This is a case of a physician who chronically took DMT augmented with phenelzine in an attempt to self-medicate refractory bipolar depression. His presentation of altered mental status, mania, and psychosis is examined in regards to his DMT use. This case discusses DMT,...

A closer look at the relationship between the default network, mind wandering, negative mood, and depression.

Cognitive, Affective, & Behavioral Neuroscience August 2017 Shaghayegh Konjedi, Reza Maleeh

By a systematic analysis of the current literature on the neural correlates of mind wandering, that is, the default network (DN), and by shedding light on some determinative factors and conditions which affect the relationship between mind wandering and negative mood, we show that (1) mind wandering per se does not necessarily have a positive correlation with negative mood and, on the higher...

[Clinical and biological predictors of ketamine response in treatment-resistant major depression: Review].

L'Encephale August 2017 B Romeo, W Choucha, P Fossati et al.

The aim of this review was to determine the clinical and biological predictors of the ketamine response. A systematic research on PubMed and PsycINFO database was performed without limits on year of publication. The main predictive factors of ketamine response, which were found in different studies, were (i) a family history of alcohol dependence, (ii) unipolar depressive disorder, and (iii)...

DOI: 10.1016/j.encep.2016.06.005 (opens in new tab) Full text (opens in new tab) Ketamine Kétamine Major depressive episode Predictors response +1

Exploring a post-traumatic stress disorder paradigm in Flinders sensitive line rats to model treatment-resistant depression II: response to antidepressant augmentation strategies.

Acta Neuropsychiatrica August 2017 Sarel Jacobus Brand, Brian Herbert Harvey

Post-traumatic stress disorder (PTSD) displays high co-morbidity with major depression and treatment-resistant depression (TRD). Earlier work demonstrated exaggerated depressive-like symptoms in a gene×environment model of TRD and an abrogated response to imipramine. We extended the investigation by studying the behavioural and monoaminergic response to multiple antidepressants, viz....

DOI: 10.1017/neu.2016.50 (opens in new tab) Full text (opens in new tab) Nmda antagonist Animal model Noradrenaline reuptake inhibitor Serotonin reuptake inhibitor +1

Oral Ketamine in Treatment-Resistant Depression: A Clinical Effectiveness Case Series.

Journal of Clinical Psychopharmacology August 2017 Maryam I Al Shirawi, Sidney H. Kennedy, Keith T. Ho et al.

The aim of the study was to assess the effectiveness, tolerability, and safety of oral ketamine as an antidepressant treatment in adults with treatment-resistant depression. We reviewed retrospective data on 22 patients with treatment-resistant depression, who failed at least 3 adequate antidepressant treatment trials and 1 adequate trial of repetitive transcranial magnetic stimulation;...